Devine, C

Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole. [electronic resource] - Parasitology Apr 2010 - 871-80 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1469-8161

10.1017/S003118200999148X doi


Animals
Cytochrome P-450 Enzyme Inhibitors
Cytochrome P-450 Enzyme System--metabolism
Enzyme Inhibitors--pharmacology
Fasciola hepatica--drug effects
Fascioliasis--drug therapy
Liver Diseases, Parasitic--drug therapy
Microscopy, Electron, Scanning
Piperonyl Butoxide--pharmacology